Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1698924

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she last met with Greater Manchester NHS Board to discuss the statutory commissioning of NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20611
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20612 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698925

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions NHS England have had with Greater Manchester NHS on their statutory responsibilities to commission NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20612
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698926

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance her Department issues NHS trusts on establishing commissioning structures for Health Technology Assessments; and whether trusts have discretion to adopt different processes.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20613
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20612 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1584998

	registered interest
	date	07/02/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insomnia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve health outcomes for people with insomnia.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	141452
	answer	answer is ministerial correction date of answer 14/02/2023 answer text <p>Through ‘Advancing Our Health: Prevention in the 2020s’, the Government committed to review the evidence on sleep and health. That review has been undertaken, and the outcomes will be published in due course.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 14/02/2023 14:56:46 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4034 label Biography information for Yvonne Fovargue

1584999

	registered interest
	date	07/02/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insomnia: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the NHS of treating patients with insomnia.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	141453
	answer	answer is ministerial correction date of answer 14/02/2023 answer text <p>No assessment has been made by the Department or NHS England of the annual cost to the National Health Service for treating patients with insomnia.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 14/02/2023 14:52:01 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4034 label Biography information for Yvonne Fovargue

1546153

	registered interest
	date	28/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Public Consultation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his planned timetable is for the publication of responses to the consultation entitled Advancing our health: prevention in the 2020s, published on 22 July 2019.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	97622
	answer	answer is ministerial correction date of answer 06/12/2022 answer text <p>We have no current plans to publish a summary of the responses to the consultation ‘Advancing our health: prevention in the 2020s’ and there are no plans to publish next steps.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 97624 question first answered 06/12/2022 15:53:43 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4034 label Biography information for Yvonne Fovargue

1546156

	registered interest
	date	28/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Public Consultation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his planned timetable is for the publication of next steps following the consultation entitled Advancing our health: prevention in the 2020s, published on 22 July 2019.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	97624
	answer	answer is ministerial correction date of answer 06/12/2022 answer text <p>We have no current plans to publish a summary of the responses to the consultation ‘Advancing our health: prevention in the 2020s’ and there are no plans to publish next steps.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 97622 question first answered 06/12/2022 15:53:43 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4034 label Biography information for Yvonne Fovargue

1544606

	registered interest
	date	22/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rheumatoid Arthritis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many rheumatoid arthritis patients received a biologic in each of the last three years.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	93513
	answer	answer is ministerial correction date of answer 25/11/2022 answer text <p>This information is not collected in the format requested.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93514 question first answered 25/11/2022 12:58:14 answering member 4527 label Biography information for Helen Whately
	tabling member	4034 label Biography information for Yvonne Fovargue

1544608

	registered interest
	date	22/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rheumatoid Arthritis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of rheumatoid arthritis patients received a biologic in the last 12 months.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	93514
	answer	answer is ministerial correction date of answer 25/11/2022 answer text <p>This information is not collected in the format requested.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93513 question first answered 25/11/2022 12:58:14 answering member 4527 label Biography information for Helen Whately
	tabling member	4034 label Biography information for Yvonne Fovargue

1544610

	registered interest
	date	22/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of severe asthma patients have been prescribed a biologic in the last 12 months.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	93515
	answer	answer is ministerial correction date of answer 29/11/2022 answer text <p>The information on the proportion of severe asthma patients prescribed a biologic is not held in the format requested. However, 3,396 patients commenced a new biologic therapy for severe asthma in the last year. All those patients considered to benefit from a biologic treatment by a specialist severe asthma team will have received the treatment.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93516 question first answered 29/11/2022 15:37:05 answering member 4527 label Biography information for Helen Whately
	tabling member	4034 label Biography information for Yvonne Fovargue